摘要
目的:探讨埃索美拉唑联合莫沙必利治疗反流性食管炎的临床疗效。方法:100例反流性食管炎患者被随即分为观察组和对照组,对照组采用奥美拉唑联合莫沙必利治疗,观察组采用埃索美拉唑联合莫沙必利治疗。结果:两组患者4w、8w时显效率及总有效率均有显著性差异(P<0.05),观察组均高于对照组,8w治疗结束时观察组除1例食道压过低的患者症状及胃镜结果无任何改善外,其余患者均有程度不同的改善。结论:埃索美拉唑联合莫沙必利治疗反流性食管炎,其显效率及总有效率均显著高于奥美拉唑与莫沙必利的联合用药,应在临床推广使用。
Objective：To discuss the effect of esomeprazole and mosapride treating reflux esophagitis.Methods：100 cases of reflux esophagitis patients were randomly divided into observation group and control group,in the control group were treated with omeprazole and mosapride;in the observation group were treated with esomeprazole and mosapride.Results：In 4 weekend and 8 weekend after treatment the incidence of a significant effect and total efficiency of two group was significantly different （P0.05）,the observation group were higher.Conclusions：Treatment of reflux esophagitis with esomeprazole and mosapride,its the incidence of a significant effect and total efficiency was significantly higher than that of omeprazole and mosapride,should be in clinical use.
出处
《医学信息（中旬刊）》
2011年第9期4365-4366,共2页
Medical Information Operations Sciences Fascicule
